Amanta Healthcare IPO Sees Exceptional Demand, Subscribed 82.57x by Day 3

Amanta Healthcare Limited's initial public offering (IPO) has demonstrated strong investor interest on its second day of subscription, with Amanta Healthcare's stock price set at ₹120-126 per share reflecting positive market reception. The ₹126 crore IPO reached 19.58 times by 4:59:35 PM on day two, indicating strong investor interest in this pharmaceutical manufacturing company incorporated in 1994.

Amanta Healthcare IPO non-institutional investors segment leads with exceptional 36.36 times subscription, whilst retail investors demonstrate strong participation at 23.28 times and qualified institutional buyers (ex-anchor) show limited interest at 0.53 times, whilst anchor investors show complete participation at 1.00 times, reflecting positive investor confidence in this company.

Amanta Healthcare IPO subscription reached strong 19.58 times on day two, led by Non-Institutional Investors (36.36x), Retail Investors (23.28x), and Qualified Institutional Buyers Ex-Anchor (0.53x). Total applications reached 5,63,646.

Subscription Status of Amanta Healthcare IPO:

Here are the subscription details for Amanta Healthcare IPO as of Day 3 (September 3, 2025, 4:59:35 PM):

Amanta Healthcare IPO Reservation

Key Highlights - Day 3:

• Overall subscription reached exceptional 82.57 times, showing extraordinary improvement from day two's 19.63 times.
• Non-institutional investors category displaying spectacular interest at 209.39 times, building substantially from day two's 36.41 times
• Retail investors showing exceptional confidence at 54.92 times, building substantially from day two's 23.35 times
• Qualified institutional buyers (ex-anchor) displaying strong growth at 35.86 times, building substantially from day two's 0.53 times
• Total applications reached 13,89,725, indicating exceptional investor participation for this mainboard IPO
• Cumulative bid amount reached ₹7,283.00 crores against the issue size of ₹126 crores
   

Amanta Healthcare IPO - Day 2 Subscription at 19.63 Times

Key Highlights - Day 2:

• Overall subscription reached strong 19.58 times, showing substantial improvement from day one's 4.62 times.
• Non-institutional investors category displaying exceptional interest at 36.36 times, building substantially from day one's 5.82 times
• Retail investors showing strong confidence at 23.28 times, building substantially from day one's 6.72 times
• Qualified institutional buyers (ex-anchor) showing modest improvement at 0.53 times, building from day one's 0.04 times
• Total applications reached 5,63,646, indicating strong investor participation for this mainboard IPO
• Cumulative bid amount reached ₹1,727.38 crores, significantly exceeding the issue size of ₹126 crores
• Amanta Healthcare IPO - Day 1 Subscription at 4.62 Times

Amanta Healthcare IPO - Day 1 Subscription at 4.62 Times

Key Highlights - Day 1:

• Overall subscription reached moderate 4.62 times, showing mixed initial investor response
• Retail investors displaying strong confidence at 6.72 times, showing robust retail appetite for pharmaceutical sector opportunity
• Non-institutional investors showing strong performance at 5.82 times, with measured HNI participation
• Qualified institutional buyers (ex-anchor) showing minimal performance at 0.04 times, indicating limited institutional appetite
• Strong retail and HNI response offset by cautious institutional participation on opening day

About Amanta Healthcare Limited

Incorporated in 1994, Amanta Healthcare Limited is an Indian pharmaceutical company specialising in the development, manufacturing and marketing of sterile liquid products, including parenteral products, using Aseptic Blow-Fill-Seal and Injection Stretch Blow Moulding technologies, manufacturing over 45 generic products and marketing through 320 distributors across domestic and international markets in 21 countries.